Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-02-23 @ 6:25 AM
Study NCT ID:
NCT01260103
Status:
WITHDRAWN
Last Update Posted:
2017-07-26
First Post:
2010-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Sponsor:
Burzynski Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Optic Nerve Glioma | View |